Correlation Between Cipher Pharmaceuticals and Avicanna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cipher Pharmaceuticals and Avicanna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cipher Pharmaceuticals and Avicanna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cipher Pharmaceuticals and Avicanna, you can compare the effects of market volatilities on Cipher Pharmaceuticals and Avicanna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cipher Pharmaceuticals with a short position of Avicanna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cipher Pharmaceuticals and Avicanna.

Diversification Opportunities for Cipher Pharmaceuticals and Avicanna

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cipher and Avicanna is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Cipher Pharmaceuticals and Avicanna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avicanna and Cipher Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cipher Pharmaceuticals are associated (or correlated) with Avicanna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avicanna has no effect on the direction of Cipher Pharmaceuticals i.e., Cipher Pharmaceuticals and Avicanna go up and down completely randomly.

Pair Corralation between Cipher Pharmaceuticals and Avicanna

If you would invest  21.00  in Avicanna on October 21, 2024 and sell it today you would earn a total of  2.00  from holding Avicanna or generate 9.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy1.61%
ValuesDaily Returns

Cipher Pharmaceuticals  vs.  Avicanna

 Performance 
       Timeline  
Cipher Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cipher Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cipher Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Avicanna 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Avicanna are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Avicanna reported solid returns over the last few months and may actually be approaching a breakup point.

Cipher Pharmaceuticals and Avicanna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cipher Pharmaceuticals and Avicanna

The main advantage of trading using opposite Cipher Pharmaceuticals and Avicanna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cipher Pharmaceuticals position performs unexpectedly, Avicanna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avicanna will offset losses from the drop in Avicanna's long position.
The idea behind Cipher Pharmaceuticals and Avicanna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities